Abstract
A novel component of the properdin system has been discribed which represents a heretofore unrecognized human serum protein. The protein has been tentatively termed the initiating factor (IF) because it functions in the initial reaction of the properdin pathway. IF is a 170,000 dalton beta-pseudoglobulin which is composed of two presumably identical 85,000 dalton chains linked by disulfide bonds. The protein reacts with antibody to nephritic factor, which is defined by its activity and is found in the serum of patients with certain nephritides. The activity of IF is heat stable. Upon treatment of serum with activators of the alternative pathway, the initial C3 convertase is assembled from IF, Factors D and C, C3, and magnesium without participation of properdin. It is the function of the enzyme to deposit C3b on the surface of the activator particles, thereby affording generation of the solid phase enzymes of the pathway, a process that is a prerequisite for properdin activation. By exposure to low pH, IF assumed the electrophoretic mobility of psi-globulin and acquired the ability to generate without activators a fluid phase C3 convertase in serum. Serum depleted of IF did not allow activation of the properdin pathway. Serum depleted of properdin did permit activation of the pathway and expression of cytolytic activity. These results raise the possibility that IF represents the recognition unit of the pathway.
MeSH Terms
Animals
Blood Proteins/immunology,isolation & purification,metabolism
Centrifugation, Density Gradient
Complement C3/metabolism
Complement System Proteins/metabolism
Electrophoresis, Agar Gel
Electrophoresis, Polyacrylamide Gel
Esterases/analysis
Hemolysis
Humans
Immune Adherence Reaction
In Vitro Techniques
Inulin/pharmacology
Peptide Initiation Factors/metabolism
Properdin/immunology,metabolism
Rabbits
Zymosan/pharmacology
gamma-Globulins
Chemicals
Blood Proteins
Complement C3
Peptide Initiation Factors
gamma-Globulins
Properdin
Inulin
Complement System Proteins
Zymosan
Esterases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Schreiber R D
Götze O
Müller-Eberhard H J
References (25)
25 references, click to expand
-
Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
J Exp Med. 1975 Apr 1;141(4):761-74
PMID: 1092789
-
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
J Exp Med. 1976 Oct 1;144(4):1076-93
PMID: 978134
-
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
J Immunol. 1976 Jan;116(1):1-7
PMID: 1245733
-
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
Science. 1954 Aug 20;120(3112):279-85
PMID: 13186838
-
Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.
Science. 1955 Sep 23;122(3169):545-9
PMID: 13255887
-
A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.
Virology. 1963 Aug;20:642-4
PMID: 14059832
-
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.
Ann N Y Acad Sci. 1964 Dec 28;121:404-27
PMID: 14240539
-
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
J Exp Med. 1965 Aug 1;122:277-98
PMID: 14316946
-
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
J Exp Med. 1976 May 1;143(5):1027-41
PMID: 177712
-
Basic mechanisms in blood coagulation.
Annu Rev Biochem. 1975;44:799-829
PMID: 237463
-
The C3-activator system: an alternate pathway of complement activation.
J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s
PMID: 4105810
-
Complement utilization by guinea pig 1 and 2-immunoglobulins through the C3 activator system.
J Immunol. 1971 Sep;107(3):920-3
PMID: 4105938
-
Activation of the alternate pathway of human complements by rabbit cells.
J Immunol. 1974 Jul;113(1):348-58
PMID: 4134064
-
The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.
J Immunol. 1970 Feb;104(2):329-34
PMID: 4189670
-
A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
J Exp Med. 1974 May 1;139(5):1249-61
PMID: 4207623
-
Fourth component of human complement: description of a three polypeptide chain structure.
J Exp Med. 1974 Nov 1;140(5):1324-35
PMID: 4424566
-
Activation of the alternate complement pathway by autologous red cell stroma.
J Exp Med. 1973 Sep 1;138(3):715-22
PMID: 4727918
-
The role of properdin in the alternate pathway of complement activation.
J Exp Med. 1974 Jan 1;139(1):44-57
PMID: 4808709
-
A simplified method for cyanogen bromide activation of agarose for affinity chromatography.
Anal Biochem. 1974 Jul;60(1):149-52
PMID: 4850305
-
DNP-antigens activate the alternate pathway of the complement system.
J Immunol. 1974 Aug;113(2):501-6
PMID: 4858625
-
Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.
J Immunol. 1971 Dec;107(6):1666-72
PMID: 5120401
-
The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.
Immunochemistry. 1970 Apr;7(4):341-56
PMID: 5464477
-
A molecular concept of the properdin pathway.
Proc Natl Acad Sci U S A. 1976 Feb;73(2):612-6
PMID: 54923
-
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
J Biol Chem. 1969 Aug 25;244(16):4406-12
PMID: 5806584
-
Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
J Exp Med. 1975 Sep 1;142(3):760-72
PMID: 1165475